141 related articles for article (PubMed ID: 8029495)
1. Mechanistic insights aid the search for CFC substitutes: risk assessment of HCFC-123 as an example.
Jarabek AM; Fisher JW; Rubenstein R; Lipscomb JC; Williams RJ; Vinegar A; McDougal JN
Risk Anal; 1994 Jun; 14(3):231-50. PubMed ID: 8029495
[TBL] [Abstract][Full Text] [Related]
2. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling.
Williams RJ; Vinegar A; McDougal JN; Jarabek AM; Fisher JW
Fundam Appl Toxicol; 1996 Mar; 30(1):55-66. PubMed ID: 8812223
[TBL] [Abstract][Full Text] [Related]
3. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW
Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
Vinegar A; Williams RJ; Fisher JW; McDougal JN
Toxicol Appl Pharmacol; 1994 Nov; 129(1):103-13. PubMed ID: 7974482
[TBL] [Abstract][Full Text] [Related]
5. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
Huwyler J; Aeschlimann D; Christen U; Gut J
Eur J Biochem; 1992 Jul; 207(1):229-38. PubMed ID: 1628651
[TBL] [Abstract][Full Text] [Related]
6. The development of environmentally acceptable fluorocarbons.
Rusch GM
Crit Rev Toxicol; 2018 Sep; 48(8):615-665. PubMed ID: 30474464
[TBL] [Abstract][Full Text] [Related]
7. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Nomiyama T; Rahier J; Lison D
Arch Toxicol; 2001 Jul; 75(5):274-83. PubMed ID: 11548120
[TBL] [Abstract][Full Text] [Related]
8. Toxicology of chlorofluorocarbon replacements.
Dekant W
Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):75-83. PubMed ID: 8722112
[TBL] [Abstract][Full Text] [Related]
9. An evaluation on the environmental consequences of residual CFCs from obsolete household refrigerators in China.
Zhao X; Duan H; Li J
Waste Manag; 2011 Mar; 31(3):555-60. PubMed ID: 21093246
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Haufroid V; Rahier J; Lison D
Arch Toxicol; 2002 Dec; 76(12):707-14. PubMed ID: 12451447
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
Urban G; Speerschneider P; Dekant W
Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
[TBL] [Abstract][Full Text] [Related]
12. Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.
Harris JW; Pohl LR; Martin JL; Anders MW
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1407-10. PubMed ID: 1996342
[TBL] [Abstract][Full Text] [Related]
13. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons.
Hoet P; Graf ML; Bourdi M; Pohl LR; Duray PH; Chen W; Peter RM; Nelson SD; Verlinden N; Lison D
Lancet; 1997 Aug; 350(9077):556-9. PubMed ID: 9284778
[TBL] [Abstract][Full Text] [Related]
14. Ten years of continuous observations of stratospheric ozone depleting gases at Monte Cimone (Italy)--comments on the effectiveness of the Montreal Protocol from a regional perspective.
Maione M; Giostra U; Arduini J; Furlani F; Graziosi F; Lo Vullo E; Bonasoni P
Sci Total Environ; 2013 Feb; 445-446():155-64. PubMed ID: 23333511
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.
Yin H; Jones JP; Anders MW
Chem Res Toxicol; 1995 Mar; 8(2):262-8. PubMed ID: 7766810
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation and toxicity in vitro of HCFC-123 and HCFC-141b: role of cytochrome P450.
Zanovello A; Ferrara R; Tolando R; Bortolato S; White IN; Manno M
Toxicol Lett; 2001 Oct; 124(1-3):139-52. PubMed ID: 11684366
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation and cytotoxicity of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) in isolated rat hepatocytes.
Ferrara R; Zanovello A; Bortolato S; White IN; Manno M
Pharmacol Toxicol; 2001 Apr; 88(4):192-7. PubMed ID: 11322177
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
Urban G; Dekant W
Xenobiotica; 1994 Sep; 24(9):881-92. PubMed ID: 7810170
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and pharmacokinetics of selected halon replacement candidates.
Dodd DE; Brashear WT; Vinegar A
Toxicol Lett; 1993 May; 68(1-2):37-47. PubMed ID: 8516773
[TBL] [Abstract][Full Text] [Related]
20. Reductive activation of HCFC-123 by methaemalbumin.
Zanovello A; Ferrara R; Manno M
Toxicol Lett; 2003 Sep; 144(1):127-36. PubMed ID: 12919730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]